Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology

Trends in Pharmacological Sciences
Shudong Wang, Peter M Fischer

Abstract

Unlike other CDKs, CDK9 does not regulate the cell cycle but promotes RNA synthesis in genetic programmes for cell growth, differentiation and viral pathogenesis. It is becoming clear that CDK9 inhibition contributes to the anticancer activity of most CDK inhibitors under clinic investigation. CDK9 was discovered in the context of HIV research because retroviruses hijack host transcription and CDK9 inhibitors might become specific antiretroviral agents, particularly as they might prevent drug resistance. Myocardial hypertrophy is a risk factor in congestive heart failure and is characterised by derepressed CDK9 activity. CDK9 inhibitors, thus, can find therapeutic application in cardiology. Although there are strong signs that CDK9 inhibition would be a useful therapeutic strategy in all three indications, the lack of selective inhibitors has so far confounded clinical development. Here we give an overview of the validity of CDK9 as a drug target and of the current knowledge of this kinase and its inhibitors.

Citations

May 6, 2014·European Journal of Medicinal Chemistry·Andreas ReicheltJennifer H Dao
Apr 29, 2014·Journal of Molecular Graphics & Modelling·Jelena RandjelovicVladimir Savic
Jun 3, 2014·BMC Research Notes·Judit Garriga, Xavier Graña
Jul 9, 2014·Annual Review of Analytical Chemistry·Erica M ForsbergJohn D Brennan
Jul 8, 2014·European Journal of Medicinal Chemistry·Aurélien PuteyBenoît Joseph
Jan 9, 2013·Journal of Molecular Modeling·Jelena RandjelovićVladimir Savić
Apr 21, 2011·Apoptosis : an International Journal on Programmed Cell Death·Xènia Garrofé-OchoaJacint Boix
Feb 19, 2011·Investigational New Drugs·Xiangrui LiuShudong Wang
Mar 24, 2011·Future Medicinal Chemistry·Oriana TabarriniVioletta Cecchetti
Feb 26, 2010·Expert Opinion on Therapeutic Patents·Hervé GalonsLaurent Meijer
Oct 27, 2015·Molecular Medicine Reports·Ya-Jun ZhuLing Li
Jan 11, 2016·Cell Reports·Ann Katrin GreifenbergMatthias Geyer
Jul 5, 2011·Antiviral Research·Miles C SmithDavid J Davido
Feb 22, 2011·Journal of Molecular Graphics & Modelling·Cheng FangZongru Guo
Mar 3, 2009·Bioorganic & Medicinal Chemistry Letters·Jeanne A GeyerNorman C Waters
Sep 10, 2015·Bioorganic & Medicinal Chemistry·Louisa J PhillipsonChristopher J Burns
Apr 13, 2011·International Journal of Cancer. Journal International Du Cancer·Xiangrui LiuShudong Wang
Mar 12, 2011·British Journal of Pharmacology·Nina BerberichRobert Fürst
Sep 14, 2010·Journal of Cellular Physiology·Józefa Węsierska-GądekOxana Komina
Sep 26, 2009·Journal of Cellular Physiology·Judit GarrigaXavier Graña
Oct 15, 2013·Journal of Cellular Physiology·Valentin Le DouceChristian Schwartz
Sep 17, 2009·Medicinal Research Reviews·Vladimír KrystofJirí Kohoutek
Mar 31, 2012·Cell Division·Havva KeskinXavier Graña
Aug 26, 2014·Clinical and Experimental Medicine·Yong XiaGuo-Quan Gao
Jun 5, 2014·International Journal of Cancer. Journal International Du Cancer·Gernot PolierMin Li-Weber
Sep 21, 2010·Chemistry & Biology·Sonja BaumliLouise N Johnson
Oct 14, 2009·Biochimica Et Biophysica Acta·Aude EchalierMartin E M Noble
Oct 23, 2012·European Journal of Medicinal Chemistry·Pawel M LukasikShudong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis